The pharmaceuticals, medicinal chemicals, seasonally adjusted index in Denmark is now at 369.1, indicating a decrease of 51.1 (-12.2%) since 2023 Q4.
Pharmaceuticals, medicinal chemicals, seasonally adjusted index in Denmark
No matching regions
Data availability:
Regions:
82
Date range: 2005 Q1 to 2024 Q1
Points:
5,455
Measure:
Index
Similar regions to Denmark
Pharmaceuticals, medicinal chemicals
Denmark Pharmaceuticals, medicinal chemicals between 2005 Q1 and 2024 Q1
| Period | Pharmaceuticals, medicinal chemicals | Change |
|---|---|---|
| 2024 Q1 | 369.1 | -51.1 |
| 2023 Q4 | 420.2 | +53.5 |
| 2023 Q3 | 366.7 | +1.7 |
| 2023 Q2 | 365.0 | +25.1 |
| 2023 Q1 | 339.9 | +69.6 |
| 2022 Q4 | 270.3 | +22.8 |
| 2022 Q3 | 247.5 | +20.5 |
| 2022 Q2 | 227.0 | +28.7 |
| 2022 Q1 | 198.3 | +21.0 |
| 2021 Q4 | 177.3 | +6.5 |
| 2021 Q3 | 170.8 | +32.6 |
| 2021 Q2 | 138.2 | -10.1 |
| 2021 Q1 | 148.3 | +17.8 |
| 2020 Q4 | 130.5 | +6.8 |
| 2020 Q3 | 123.7 | -9.7 |
| 2020 Q2 | 133.4 | +2.2 |
| 2020 Q1 | 131.2 | -9.2 |
| 2019 Q4 | 140.4 | -7.9 |
| 2019 Q3 | 148.3 | +10.0 |
| 2019 Q2 | 138.3 | +5.4 |
| 2019 Q1 | 132.9 | -10.3 |
| 2018 Q4 | 143.2 | +29.0 |
| 2018 Q3 | 114.2 | -0.3 |
| 2018 Q2 | 114.5 | +0.8 |
| 2018 Q1 | 113.7 | -5.1 |
| 2017 Q4 | 118.8 | +0.3 |
| 2017 Q3 | 118.5 | +1.0 |
| 2017 Q2 | 117.5 | -1.9 |
| 2017 Q1 | 119.4 | -2.3 |
| 2016 Q4 | 121.7 | +31.3 |
| 2016 Q3 | 90.4 | -18.9 |
| 2016 Q2 | 109.3 | +4.4 |
| 2016 Q1 | 104.9 | +18.3 |
| 2015 Q4 | 86.6 | -19.0 |
| 2015 Q3 | 105.6 | -4.2 |
| 2015 Q2 | 109.8 | +11.9 |
| 2015 Q1 | 97.9 | -3.5 |
| 2014 Q4 | 101.4 | -5.5 |
| 2014 Q3 | 106.9 | -1.6 |
| 2014 Q2 | 108.5 | -9.4 |
| 2014 Q1 | 117.9 | +0.7 |
| 2013 Q4 | 117.2 | +18.4 |
| 2013 Q3 | 98.8 | -4.6 |
| 2013 Q2 | 103.4 | +1.9 |
| 2013 Q1 | 101.5 | -2.2 |
| 2012 Q4 | 103.7 | +1.4 |
| 2012 Q3 | 102.3 | +5.4 |
| 2012 Q2 | 96.9 | -5.6 |
| 2012 Q1 | 102.5 | +12.7 |
| 2011 Q4 | 89.8 | +4.3 |
| 2011 Q3 | 85.5 | -5.7 |
| 2011 Q2 | 91.2 | +13.0 |
| 2011 Q1 | 78.2 | -3.7 |
| 2010 Q4 | 81.9 | +2.9 |
| 2010 Q3 | 79.0 | 0.0 |
| 2010 Q2 | 79.0 | +9.7 |
| 2010 Q1 | 69.3 | +1.7 |
| 2009 Q4 | 67.6 | -7.0 |
| 2009 Q3 | 74.6 | -0.4 |
| 2009 Q2 | 75.0 | -1.9 |
| 2009 Q1 | 76.9 | +5.0 |
| 2008 Q4 | 71.9 | -5.5 |
| 2008 Q3 | 77.4 | +2.8 |
| 2008 Q2 | 74.6 | +3.5 |
| 2008 Q1 | 71.1 | -10.9 |
| 2007 Q4 | 82.0 | +7.0 |
| 2007 Q3 | 75.0 | -4.9 |
| 2007 Q2 | 79.9 | 0.0 |
| 2007 Q1 | 79.9 | -4.3 |
| 2006 Q4 | 84.2 | +1.2 |
| 2006 Q3 | 83.0 | +1.1 |
| 2006 Q2 | 81.9 | -7.7 |
| 2006 Q1 | 89.6 | +6.0 |
| 2005 Q4 | 83.6 | -6.2 |
| 2005 Q3 | 89.8 | +1.4 |
| 2005 Q2 | 88.4 | +13.8 |
| 2005 Q1 | 74.6 |